Dhampur Bio Organics Limited has announced a significant change in its senior management team with the resignation of a key technology executive. The company informed stock exchanges about this development in compliance with regulatory requirements.

Senior Management Departure

Mr. Naresh Kumar Pathak, who served as Vice President - Information Technology and Chief Digital & Information Officer (VP IT & CDIO), has tendered his resignation from the company. The resignation letter was submitted on March 11, 2026, citing personal reasons for his departure from the senior management position.

Regulatory Compliance

The company has fulfilled its disclosure obligations under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The announcement was made to both major stock exchanges where the company's shares are listed.

Formal Documentation

The resignation process included proper documentation with Mr. Pathak addressing his resignation letter to the Chief Human Resource Officer. In his brief resignation letter, he acknowledged the opportunity to serve the organization and requested acceptance of his resignation due to personal circumstances.

Company Secretary and Compliance Officer Ashu Rawat signed the regulatory filing, ensuring all required disclosures were made to the stock exchanges. The company provided comprehensive details including the reason for change, effective date, and other particulars as mandated by SEBI regulations.

Management Transition

The departure of the VP IT & CDIO represents a change in the company's technology leadership structure. Mr. Pathak held a senior position overseeing information technology operations and digital transformation initiatives as the Chief Digital & Information Officer.

Dhampur Bio Organics Limited has announced the board approval for establishing a wholly owned subsidiary in the United Arab Emirates, marking a significant step in the company's international expansion strategy. The decision was taken during the Board of Directors meeting held on February 26, 2026, with formal disclosure made to stock exchanges under SEBI regulations.

Board Meeting and Regulatory Disclosure

The Board of Directors meeting commenced at 12:30 P.M. (IST) and concluded at 02:10 P.M. (IST) on Thursday, February 26, 2026. Following the approval, the company issued formal notifications to BSE Limited and National Stock Exchange of India Limited pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Subsidiary Investment Structure

The new subsidiary will be established as a wholly owned entity of Dhampur Bio Organics Limited, ensuring complete control and ownership by the parent company. The financial commitment represents a strategic investment in the Middle East market:

Business Operations and Industry Focus

The UAE subsidiary will operate across multiple segments within the food and consumer goods sector, leveraging the region's strategic position as a trading hub:

• Trading and distribution of sugar products
• Packaging of sugar and other FMCG products
• Futures trading in sugar and allied products
• Distribution of various FMCG items

This diversified approach positions the subsidiary to capture multiple revenue streams within the regional market while expanding Dhampur Bio Organics' international footprint.

Regulatory Compliance and Approvals

The incorporation process adheres to comprehensive regulatory requirements across multiple jurisdictions as outlined in the company's formal disclosure:

Implementation Timeline

While the board has granted approval, the actual incorporation remains pending approval from relevant UAE authorities. The company has committed to providing necessary updates regarding the subsidiary's name and incorporation details once the wholly owned subsidiary is formally established and receives regulatory clearance. The formal disclosure was signed by Company Secretary & Compliance Officer Ashu Rawat on February 26, 2026.